Abstract: This application relates to new C-type natriuretic peptide (CNP) compounds, pharmaceutical compositions comprising these compounds, and these compounds for use as medicaments.
| # | Name | Date |
|---|---|---|
| 1 | 202547051660-STATEMENT OF UNDERTAKING (FORM 3) [29-05-2025(online)].pdf | 2025-05-29 |
| 2 | 202547051660-Sequence Listing in PDF [29-05-2025(online)].pdf | 2025-05-29 |
| 3 | 202547051660-PRIORITY DOCUMENTS [29-05-2025(online)].pdf | 2025-05-29 |
| 4 | 202547051660-POWER OF AUTHORITY [29-05-2025(online)].pdf | 2025-05-29 |
| 5 | 202547051660-FORM 1 [29-05-2025(online)].pdf | 2025-05-29 |
| 6 | 202547051660-DRAWINGS [29-05-2025(online)].pdf | 2025-05-29 |
| 7 | 202547051660-DECLARATION OF INVENTORSHIP (FORM 5) [29-05-2025(online)].pdf | 2025-05-29 |
| 8 | 202547051660-COMPLETE SPECIFICATION [29-05-2025(online)].pdf | 2025-05-29 |
| 9 | 202547051660-FORM 18 [30-05-2025(online)].pdf | 2025-05-30 |
| 10 | 202547051660-Proof of Right [24-11-2025(online)].pdf | 2025-11-24 |
| 11 | 202547051660-FORM 3 [24-11-2025(online)].pdf | 2025-11-24 |